当前位置: X-MOL 学术Trends Neurosci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Seizing Control of KCC2: A New Therapeutic Target for Epilepsy
Trends in Neurosciences ( IF 15.9 ) Pub Date : 2017-09-01 , DOI: 10.1016/j.tins.2017.06.008
Yvonne E. Moore , Matt R. Kelley , Nicholas J. Brandon , Tarek Z. Deeb , Stephen J. Moss

Deficits in GABAergic inhibition result in the abnormal neuronal activation and synchronization that underlies seizures. However, the molecular mechanisms responsible for transforming a normal brain into an epileptic one remain largely unknown. Hyperpolarizing inhibition mediated by type A GABA (GABAA) receptors is dependent on chloride extrusion by the neuron-specific type 2K+-Cl- cotransporter (KCC2). Loss-of-function mutations in KCC2 are a known cause of infantile epilepsy in humans and KCC2 dysfunction is present in patients with both idiopathic and acquired epilepsy. Here we discuss the growing evidence that KCC2 dysfunction has a central role in the development and severity of the epilepsies.

中文翻译:

控制 KCC2:癫痫的新治疗靶点

GABA 能抑制的缺陷导致异常的神经元激活和同步,这是癫痫发作的基础。然而,负责将正常大脑转变为癫痫大脑的分子机制在很大程度上仍然未知。由 A 型 GABA (GABAA) 受体介导的超极化抑制依赖于神经元特异性 2K+-Cl-协同转运蛋白 (KCC2) 的氯化物挤出。KCC2 功能丧失突变是人类婴儿癫痫的已知原因,特发性和获得性癫痫患者都存在 KCC2 功能障碍。在这里,我们讨论了越来越多的证据,即 KCC2 功能障碍在癫痫的发展和严重程度中起着核心作用。
更新日期:2017-09-01
down
wechat
bug